FIELD: medicine; oncology.
SUBSTANCE: invention is related to the use of dioxydine - 2.3 di(hydroxymethyl)xynoxaline-1.4-dioxide as an anti-tumoral means. For the first time it was found that antibacterial preparation dioxydine has cytotoxic impact on cancer cells without any toxic impact on healthy cells.
EFFECT: enhanced anti-tumoral effect of hyperthermia when applied in combination with dioxydine.
2 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SOLID MALIGNANT TUMOURS IN MAMMALS | 2024 |
|
RU2841088C2 |
| MEDICINAL PRODUCT FOR TREATMENT OF BREAST CANCER | 2017 |
|
RU2657545C1 |
| COMPOSITION FOR KILLING TNF-α-SENSITIVE TUMOR CELLS | 2002 |
|
RU2209078C1 |
| USE OF GOLD POLYACRYLATE AS A HUMAN MELANOMA CELL GROWTH INHIBITOR | 2018 |
|
RU2708626C1 |
| MEANS TO INHIBIT TUMOR GROWTH | 1995 |
|
RU2106146C1 |
| POLYPEPTIDES FOR TREATING ONCOLOGICAL DISEASES | 2017 |
|
RU2728870C2 |
| METHOD FOR INCREASING RESISTANCE OF HUMAN ORGANISM TO TUMORS | 1996 |
|
RU2071367C1 |
| DI[(FURAN-3-CARBOXYLATE-O)-(2,9-DIMETHYL-1,10-PHENANTHROLINE-N,N')-COPPER(II)] WITH ANTIPROLIFERATIVE AND ANTIMYCOBACTERIAL ACTIVITY | 2023 |
|
RU2815425C1 |
| ANTITUMOR COMPOSITION OF DOXORUBICIN WITH ATP INHIBITOR-DEPENDENT REVERSE CELL TRANSPORTER | 2018 |
|
RU2680834C1 |
| 1-HEXADECYL-R-(-)-3-OXY-1-AZONIABICYCLO[2.2.2]OCTANE BROMIDE AS IMMUNOMODULATOR WITH ANTITUMOR, BACTERIOSTATIC AND ANTI-AGGREGATION PROPERTIES AND METHOD FOR ITS PREPARING | 2005 |
|
RU2296761C2 |
